Skip to main content
Log in

Exogenous Ochronosis: A Comprehensive Review of the Diagnosis, Epidemiology, Causes, and Treatments

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Exogenous ochronosis (EO) can be an unintended psychologically troubling condition for patients who are already being treated for longer-term hyperpigmentation disorders such as melasma. Early diagnosis is key in order that the offending agent can be stopped to prevent further disfiguring discoloration. EO can be diagnosed in the right clinical setting with the aid of dermatoscopy, which can assist in early diagnosis and may negate the need for a biopsy. Laser modalities using Q-switched lasers of longer wavelengths and combination laser dermabrasion treatments have shown the most significant results with minimal adverse events. However, further large-scale studies are needed to determine optimal treatment modalities. Although considered uncommon, the incidence of EO will likely continue to increase with the growth of immigrant populations and the use of skin-lightening agents above the FDA’s recommended over-the-counter concentrations, without the guidance of a dermatologist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Findlay GH. Ochronosis. Clin Dermatol. 1989;7(2):28–35.

    CAS  PubMed  Google Scholar 

  2. Mistry JB, Bukhari M, Taylor AM. Alkaptonuria. Rare Dis. 2013;1:e27475.

    PubMed Central  PubMed  Google Scholar 

  3. Beddard AP, Plumtre CM. A further note on ochronosis associated with carboluria. Q S Med. 1912;5:505–7.

    Google Scholar 

  4. Charlin R, Barcaui CB, Kac BK, Soares DB, Rabello-Fonseca R, Azulay-Abulafia L. Hydroquinone-induced exogenous ochronosis: a report of four cases and usefulness of dermoscopy. Int J Dermatol. 2008;47(1):19–23.

    PubMed  Google Scholar 

  5. Penneys NS. Ochronosis like pigmentation from hydroquinone bleaching creams. Arch Dermatol. 1985;121(10):1239–40.

    CAS  PubMed  Google Scholar 

  6. Findlay GH, Morrison JG, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975;93(6):613–22.

    CAS  PubMed  Google Scholar 

  7. Levin CY, Maibach H. Exogenous ochronosis. An update on clinical features, causative agents and treatment options. Am J Clin Dermatol. 2001;2(4):213–7.

    CAS  PubMed  Google Scholar 

  8. Dogliotti M, Leibowitz M. Granulomatous ochronosis: a cosmetic-induced skin disorder in Blacks. S Afr Med J. 1979;56(19):757–60.

    CAS  PubMed  Google Scholar 

  9. Jacyk WK. Annular granulomatous lesions in exogenous ochronosis are manifestation of sarcoidosis. Am J Dermatopathol. 1995;17(1):18–22.

    CAS  PubMed  Google Scholar 

  10. Khunger N, Kandhari R. Dermoscopic criteria for differentiating exogenous ochronosis from melasma. Indian J Dermatol Venereol Leprol. 2013;79(6):819–21.

    PubMed  Google Scholar 

  11. Liu WC, Tey HL, Lee JS, Goh BK. Exogenous ochronosis in a Chinese patient: use of dermoscopy aids early diagnosis and selection of biopsy site. Singapore Med J. 2014;55(1):e1–3.

    PubMed Central  PubMed  Google Scholar 

  12. Gil I, Segura S, Martinez-Escala E, Lloreta J, Puig S, Velez M, et al. Dermoscopic and reflectance confocal microscopic features of exogenous ochronosis. Arch Dermatol. 2010;146(9):1021–5.

    PubMed  Google Scholar 

  13. Cullison D, Abele DC, O’Quinn JL. Localized exogenous ochronosis. J Am Acad Dermatol. 1983;8(6):882–9.

    CAS  PubMed  Google Scholar 

  14. Zawar V, Tan S-K. Exogenous ochronosis: a review for clinicians. Expert Rev Dermatol. 2012;7(2):171–80.

    CAS  Google Scholar 

  15. US FDA. Docket no. 78N-0065; comments PRT 4 and PRT 5. US FDA; 1998.

  16. US Census Bureau. US Census Bureau projections show a slower growing, older, more diverse nation a half century from now. 12 Dec 2012. Available at: https://www.census.gov/newsroom/releases/archives/population/cb12-243.html.

  17. Galindo GR, Mayer JA, Slymen D, Almaguer DD, Clapp E, Pichon LC, et al. Sun sensitivity in 5 US ethnoracial groups. Cutis. 2007;80(1):25–30.

    PubMed  Google Scholar 

  18. Werlinger KD, Guevara IL, Gonzalez CM, Rincon ET, Caetano R, Haley RW, et al. Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, Tex. Arch Dermatol. 2007;143(3):424–5.

    PubMed  Google Scholar 

  19. Sivayathorn A. Melasma in orientals. Clin Drug Invest. 1995;10(Suppl 2):34.

    Google Scholar 

  20. Tan SK. Exogenous ochronosis in ethnic Chinese Asians: a clinicopathological study, diagnosis and treatment. J Eur Acad Dermatol Venereol. 2011;25(7):842–50.

    CAS  PubMed  Google Scholar 

  21. Bruce S, Tschen JA, Chow D. Exogenous ochronosis resulting from quinine injections. J Am Acad Dermatol. 1986;15(2 Pt 2):357–61.

    CAS  PubMed  Google Scholar 

  22. Ribas J, Schettini AP. Cavalcante Mde S. Exogenous ochronosis hydroquinone induced: a report of four cases. An Bras Dermatol. 2010;85(5):699–703.

    PubMed  Google Scholar 

  23. Olumide YM, Akinkugbe AO, Altraide D, Mohammed T, Ahamefule N, Ayanlowo S, et al. Complications of chronic use of skin lightening cosmetics. Int J Dermatol. 2008;47(4):344–53.

    PubMed  Google Scholar 

  24. Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, et al. Final amended safety assessment of hydroquinone as used in cosmetics. Int J Toxicol. 2010;29(6 Suppl):274S–87S.

    CAS  PubMed  Google Scholar 

  25. Levitt J. The safety of hydroquinone: a dermatologist’s response to the 2006 Federal Register. J Am Acad Dermatol. 2007;57(5):854–72.

    PubMed  Google Scholar 

  26. Jow T, Hantash BM. Hydroquinone-induced depigmentation: case report and review of the literature. Dermatitis. 2014;25(1):e1–5.

    Article  PubMed  Google Scholar 

  27. Diven DG, Smith EB, Pupo RA, Lee M. Hydroquinone-induced localized exogenous ochronosis treated with dermabrasion and CO2 laser. J Dermatol Surg Oncol. 1990;16(11):1018–22.

    CAS  PubMed  Google Scholar 

  28. Singh A, Ramesh V. Exogenous ochronosis. Indian J Med Res. 2014;139:327.

    PubMed Central  PubMed  Google Scholar 

  29. Schulz EJ, Summers B, Summers RS. Inappropriate treatment of cosmetic ochronosis with hydroquinone. S Afr Med J. 1988;73(1):59–60.

    CAS  PubMed  Google Scholar 

  30. Camarasa JG, Serra-Baldrich E. Exogenous ochronosis with allergic contact dermatitis from hydroquinone. Contact Dermatitis. 1994;31(1):57–8.

    Article  CAS  PubMed  Google Scholar 

  31. Howard KL, Furner BB. Exogenous ochronosis in a Mexican–American woman. Cutis. 1990;45(3):180–2.

    CAS  PubMed  Google Scholar 

  32. Lawrence N, Bligard CA, Reed R, Perret WJ. Exogenous ochronosis in the United States. J Am Acad Dermatol. 1988;18(5 Pt 2):1207–11.

    CAS  PubMed  Google Scholar 

  33. Martin RF, Sanchez JL, Gonzalez A, Lugo-Somolinos A, Ruiz H. Exogenous ochronosis. P R Health Sci J. 1992;11(1):23–6.

    PubMed  Google Scholar 

  34. Lang PG Jr. Probable coexisting exogenous ochronosis and mercurial pigmentation managed by dermabrasion. J Am Acad Dermatol. 1988;19(5 Pt 2):942–6.

    PubMed  Google Scholar 

  35. Hoshaw RA, Zimmerman KG, Menter A. Ochronosis like pigmentation from hydroquinone bleaching creams in American blacks. Arch Dermatol. 1985;121(1):105–8.

    CAS  PubMed  Google Scholar 

  36. Fisher AA. Tetracycline treatment for sarcoid-like ochronosis due to hydroquinone. Cutis. 1988;42(1):19–20.

    CAS  PubMed  Google Scholar 

  37. Moche MJ, Glassman SJ, Modi D, Grayson W. Cutaneous annular sarcoidosis developing on a background of exogenous ochronosis: a report of two cases and review of the literature. Clin Exp Dermatol. 2010;35(4):399–402.

    CAS  PubMed  Google Scholar 

  38. Bellew SG, Alster TS. Treatment of exogenous ochronosis with a Q-switched alexandrite (755 nm) laser. Dermatol Surg. 2004;30(4 Pt 1):555–8.

    PubMed  Google Scholar 

  39. Chaptini C, Huilgol SC. Erbium-doped yttrium aluminium garnet ablative laser treatment for endogenous ochronosis. Australas J Dermatol. doi:10.1111/ajd.12199. Epub 10 Oct 2014.

  40. Kramer KE, Lopez A, Stefanato CM, Phillips TJ. Exogenous ochronosis. J Am Acad Dermatol. 2000;42(5 Pt 2):869–71.

    CAS  PubMed  Google Scholar 

  41. Lee MD, Weiss E. Treatment of exogenous ochronosis with advanced fluorescence technology. Dermatol Surg. 2014;40(9):1046–8.

    CAS  PubMed  Google Scholar 

  42. Tan SK. Exogenous ochronosis: successful outcome after treatment with Q-switched Nd:YAG laser. J Cosmet Laser Ther. 2013;15(5):274–8.

    PubMed  Google Scholar 

  43. Romero SA, Pereira PM, Mariano AV, Francesconi F, Francesconi VA. Use of dermoscopy for diagnosis of exogenous ochronosis. An Bras Dermatol. 2011;86(4 Suppl 1):S31–4.

    PubMed  Google Scholar 

  44. Kanechorn-Na-Ayuthaya P, Niumphradit N, Aunhachoke K, Nakakes A, Sittiwangkul R, Srisuttiyakorn C. Effect of combination of 1064 nm Q-switched Nd:YAG and fractional carbon dioxide lasers for treating exogenous ochronosis. J Cosmet Laser Ther. 2013;15(1):42–5.

    PubMed  Google Scholar 

Download references

Acknowledgments

Brian J. Simmons, Robert D. Griffith, Fleta N. Bray, Leyre A. Falto-Aizpurua, and Keyvan Nouri have no conflicts of interest to declare. No funding was used in the design and conduct of the study, collection, management, analysis and interpretation of data, preparation, review or approval of the manuscript, or in the decision to submit the manuscript for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brian J. Simmons.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Simmons, B.J., Griffith, R.D., Bray, F.N. et al. Exogenous Ochronosis: A Comprehensive Review of the Diagnosis, Epidemiology, Causes, and Treatments. Am J Clin Dermatol 16, 205–212 (2015). https://doi.org/10.1007/s40257-015-0126-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-015-0126-8

Keywords

Navigation